Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Market Chatter: South Korea To Give Pfizer's Jab As Second Dose Instead Of AstraZeneca's Vaccine

06/18/2021 | 06:05am EDT


ę MT Newswires 2021
All news about PFIZER, INC.
05:05pHealth Care Climbs On Strong Earnings -- Health Care Roundup
DJ
01:02pModerna says COVID-19 vaccine supply outside United States to slow down
RE
10:37aVIATRIS : US District Court Dismisses Class Action Suit Against Viatris, Pfizer ..
MT
09:28aPFIZER : FDA asks Pfizer, Moderna to widen trials for COVID-19 vaccines in child..
AQ
06:12aManufacturing Woes Plague Shipment of Moderna COVID-19 Jab to South Korea
MT
04:59aOmega Diagnostics Group Notes Use of Test in Study Tracking COVID-19 Antibody..
MT
02:52aSINOVAC BIOTECH : Antibodies from Sinovac's COVID-19 shot fade after about 6 mon..
RE
02:03aArtios raises USD153m in Series C financing
DJ
12:20aEMEA MORNING BRIEFING : Stocks to Struggle at -2-
DJ
07/26PFIZER : Moderna expanding kids vaccine study to better assess safety
AQ
More news
Financials (USD)
Sales 2021 72 063 M - -
Net income 2021 17 129 M - -
Net Debt 2021 27 333 M - -
P/E ratio 2021 14,3x
Yield 2021 3,74%
Capitalization 236 B 236 B -
EV / Sales 2021 3,65x
EV / Sales 2022 4,15x
Nbr of Employees 78 500
Free-Float 59,2%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Last Close Price 42,10 $
Average target price 42,72 $
Spread / Average Target 1,47%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.14.37%234 040
JOHNSON & JOHNSON9.21%452 602
ROCHE HOLDING AG11.50%327 852
NOVARTIS AG-0.17%221 954
ELI LILLY AND COMPANY44.05%221 084
ABBVIE INC.9.93%208 043